Roger Perl­mut­ter builds Eikon's pipeline with deal-mak­ing flur­ry, rais­ing $106M more

Eikon Ther­a­peu­tics an­nounced three busi­ness de­vel­op­ment deals on Thurs­day, ef­fec­tive­ly drop­ping in a pipeline of can­cer drugs along­side more than $100 mil­lion in fresh fund­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER